ClinicalTrials.Veeva

Menu

Donor After Circulatory Death Heart CAP Trial

TransMedics logo

TransMedics

Status

Completed

Conditions

Heart Transplant

Treatments

Device: Transplant

Study type

Interventional

Funder types

Industry

Identifiers

NCT04615182
OCS-CAR-08242020

Details and patient eligibility

About

The Portable Organ Care System (OCS™) Heart for Resuscitating, Preserving and Assessing Hearts Donated after Circulatory Death Continued Access Protocol (OCS DCD Heart CAP)

Full description

To enable continued clinical access to DCD heart transplantation in the U.S. and to continue to collect additional data on the performance of the OCS Heart System to resuscitate, preserve and assess hearts donated after circulatory death for transplantation to increase the pool of donor hearts available for transplantation.

Enrollment

90 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Recipient Inclusion Criteria:

  • • Primary heart transplant candidates

    • Age ≥ 18 years old
    • Signed: (1) written informed consent document; (2) authorization to use and disclose protected health information; and (3) consent to TransMedics' use of recipients' UNOS/OPTN data and recipients' INTERMACS data.

Recipient Exclusion Criteria:

  • Prior solid organ or bone marrow transplant

    • Chronic use of hemodialysis or diagnosis of chronic renal insufficiency
    • Multi-organ transplant.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

90 participants in 1 patient group

OCS Preservation
Experimental group
Treatment:
Device: Transplant

Trial documents
1

Trial contacts and locations

25

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems